Don’t miss out on the latest pharmacy insights in the Total Pharmacy October issue.
Total Pharmacy
Latest News
Total Pharmacy Podcasts
All News
Advertisement
Adding to the mail-order options within big chain pharmacy, Walmart is promising prescription delivery in as quickly as 30 minutes.
Nina Vadiei, PharmD, BCPP, a clinical associate professor at UT Austin and a clinical pharmacy specialist in psychiatry at San Antonio State Hospital, discusses her career as a psychiatric pharmacist.
Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, discusses what sessions he is looking forward to and key themes he expects to be the topic of conversation at NCPA 2024.
David Pope, PharmD, Chief Pharmacy Officer at XiFin, joined Drug Topics to discuss value-based care and how it has changed the way pharmacy operates.
The National Community Pharmacists Association surveyed over 4000 independent pharmacy owners and managers for their thoughts on the 10 drugs selected for Medicare price negotiations.
James Rider, PharmD, shared his experiences as a pharmacy manager at CVS.
David Pope, PharmD, Chief Pharmacy Officer at XiFin, discussed pharmacy benefit managers and their impact on value-based care within pharmacies.
In an installment of Drug Topics’ 5 Questions With a Pharmacist, Stevie Veach of MercyOne Pharmacy in Dubuque, Iowa, talked about her pharmacy’s offerings and how they serve her community’s patients.
Advertisement
David Pope, PharmD, Chief Pharmacy Officer at XiFin, further discussed value-based care and his company’s ongoing collaboration with pharmacies across the country.
Drug Topics sat down with Adam J. James, PharmD, to discuss learnings from his extensive experience at Rite Aid.
David Pope, PharmD, Chief Pharmacy Officer at XiFin, shared his thoughts on value-based care and how it is used within a pharmacy setting.
Jon Minkin, enterprise account executive at NimbleRx, shared how his company can help independent pharmacies unlock revenue opportunities.
Erin Albert, vice president of pharmacy relations and chief privacy officer at Mark Cuban Cost Plus Drug Company, PBC, discussed drug pricing and what her company is doing to revolutionize transparency.
In an interview with Drug Topics, TaQuina Warren, PharmD, discussed what it means to serve her community and how she has garnered a reputation within her profession.
Emily Endres, BSPS, vice president of pharmacy at PQS by Innovaccer, provides insights into the industry’s next phase.
On October 3,2024, Texas Attorney General Ken Paxton issued the lawsuit, which involves Eli Lilly, Express Scripts, CVS Pharmacy, and other pharmaceutical entities.
In an installment of Drug Topics’ 5 Questions With a Pharmacist, Anthony Minniti of Bell Pharmacy in Camden, New Jersey, discussed pharmacy in his community and the challenges that come with it.
Drug Topics sat down with Benjamin Jolley, PharmD, of Jolley’s Compounding Pharmacy, to discuss the pharmacy industry and his experience in a myriad of roles within the profession.
Adherence interventions and comprehensive reviews can reduce health care costs, boost revenue, and improve patient outcomes.
The 70-plus-page lawsuit is directed at Express Scripts for its dealings with drug manufacturers in fueling the US opioid crisis.
Medication therapy management can change the trajectory of patient health outcomes. Here is how pharmacists can ensure adherence and compensation.
A roundtable session discussed the real-world implications of applying DIR fees at the point of sale rather than through retroactive clawback.
See what’s trending in pharmacy with a preview of the Total Pharmacy October issue.
Researchers analyzed the impact of real-time prescription benefits on prescribing patterns by evaluating subsequent fill rates and copay costs.
Advertisement
Advertisement
Trending on Drug Topics
1
Oral Semaglutide Show Promise as New Benchmark for Diabetes Care, Cardiovascular Protection
2
Opioid Overdose Deaths Fall by 34% in 2025 | ASHP Midyear 2025
3
Limited Clinical Data Impact Cannabis Integration Into Standard Care | ASHP Midyear 2025
4
What TrumpRx Means for Independent Pharmacies and Their Patients
5
